A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
A phase 1/2 trial of VMD-102 in hepatocellular carcinoma, uveal melanoma, renal cell carcinoma, non-small-cell lung cancer and colorectal cancer, run by VM Discovery, Inc., now recruiting.
Overview
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors is a phase 1/2 interventional study registered as NCT07636785 by VM Discovery, Inc., with 111 participants planned, started 2026-07-16 and due to reach its primary completion in 2031-05. Interventions recorded: VMD-102.
Similar pages
not linked directly; found by shared links- TrialA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Shares Renal cell carcinoma, Colorectal cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialEvaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialPhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Shares Colorectal cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Shares Colorectal cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialTT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialPhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Shares Colorectal cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialA Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
Shares Uveal melanoma and the tag pipeline.